1-15 of 15
Douglas W. Sborov, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Griffin Study Update

Peter M. Voorhees, MD, Jonathan L. Kaufman, MD, Jacob P. Laubach, MD, Douglas W. Sborov, MD MSc, Brandi Reeves, MD, Cesar Rodriguez, MD, Ajai Chari, MD, Rebecca W. Silbermann, MD, Luciano J. Costa, MD PhD, Larry D. Anderson, MD PhD, Nitya Nathwani, MD, Nina D. Shah, MD, Yvonne A. Efebera, MD MPH, Caitlin L. Costello, MD, Andrzej Jakubowiak, MD PhD, Tanya M. Wildes, MD, Robert Z. Orlowski, MD PhD, Kenneth H. Shain, MD PhD, Andrew J. Cowan, MD, Sean Murphy, Yana Lutska, PharmD, Huiling Pei, PhD, Jon Ukropec, PhD, Jessica Vermeulen, MD PhD, Carla de Boer, Daniela Hoehn, MD PhD, Thomas S. Lin, MD PhD, Paul G. Richardson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 691.
https://doi.org/10.1182/blood-2019-123465
Published: 2019
Journal Articles

Oncolytics Virus Replication Using Pelareorep (Reolysin) and Carfilzomib in Relapsed Myeloma Patients Increases PD-L1 Expression with Clinical Responses

Craig C Hofmeister, MDMPH, Douglas W. Sborov, MD MS, Domenico Viola, Ada Dona, Gerald J Nuovo, PhD, Don M. Benson, Jr., MD PhD, Sagar Lonial, MD, Jonathan L Kaufman, MD, Ajay K Nooka, MD MPH, Leonard Heffner, MD, Madhav V Dhodapkar, MD, Flavia Pichiorri, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2655.
https://doi.org/10.1182/blood-2018-99-113500
Published: 2018
Journal Articles

Lenalidomide and Vorinostat Maintenance after Autologous Transplant in Multiple Myeloma- Long Term Follow-up

Nidhi Sharma, PhD MS, Nita Williams, BS, Ashley E. Rosko, MD, Don M. Benson, Jr., MD PhD, Maria Chaudhry, MD, Craig C Hofmeister, MD MPH, Douglas W. Sborov, MD MS, Yvonne Efebera, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2155.
https://doi.org/10.1182/blood-2018-99-116460
Published: 2018
Journal Articles

Immunomodulatory Effects of HDACi in Combination with Checkpoint Blockade and Lenalidomide in the Immunosuppressive Multiple Myeloma Bone Marrow Microenvironment

Greg D Whitehill, BS, Alicia Chivers, MS, Bryan Danielson, PhD, Julien SR Tessier, MS, Gabriela Hernandez Duran, Gabrielle L Bender, BS, Douglas W. Sborov, MD MSc, Craig C Hofmeister, MDMPH, James Bradner, MD, Teru Hideshima, MD PhD, Kenneth C Anderson, MD, Gullu Gorgun, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4422.
https://doi.org/10.1182/blood.V130.Suppl_1.4422.4422
Published: 2017
Journal Articles

Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma

Sabarinath Venniyil Radhakrishnan, MBBS, MD, Tim Luetkens, MD, Sara Yousef, PhD, Neelam Bhardwaj, PhD, Mary Nicole Steinbach, NP, Janet Weidner, Christa Shorter, BSc, Douglas W. Sborov, MD MSc, Djordje Atanackovic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3142.
https://doi.org/10.1182/blood.V130.Suppl_1.3142.3142
Published: 2017
Journal Articles

"In Vivo Vaccination" Effect in Clinical Responders to Anti-Myeloma Monoclonal Antibody Isatuximab

Tim Luetkens, MD, Sara Yousef, PhD, Christa Shorter, BSc, Srinivas K. Tantravahi, MBBS, Mary Nicole Steinbach, NP, Janet Weidner, Douglas W. Sborov, MD MSc, Djordje Atanackovic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1830.
https://doi.org/10.1182/blood.V130.Suppl_1.1830.1830
Published: 2017
Journal Articles

The Majority of Myeloma Patients Are Vitamin D Deficient, Unrelated to Survival or Cytogenetics

Samantha Hudzik, Beau Snoad, Luay Mousa, MD, Douglas W Sborov, MD MS, Nita Williams, Desiree Jones, Craig C Hofmeister, MD MPH
Journal: Blood
Blood (2015) 126 (23): 5336.
https://doi.org/10.1182/blood.V126.23.5336.5336
Published: 2015
Journal Articles

Geriatric Assessment Metrics Are Associated with Hospital Length of Stay in Pre-Bone Marrow Transplant Myeloma Patients

Ashley E Rosko, MD, Craig C Hofmeister, MD MPH, Yvonne A Efebera, MD, Don M Benson, MD PhD, Douglas W Sborov, MD MS, Samantha Jaglowski, MD MPH, Steve Devine, MD, Tanya M Wildes, MD MSCI, James Gillahan, Desiree Jones, Ying Huang, MA, MS, Christin E Burd, PhD
Journal: Blood
Blood (2015) 126 (23): 3200.
https://doi.org/10.1182/blood.V126.23.3200.3200
Published: 2015
Journal Articles

Reolysin Combined with Carfilzomib for Treatment of Relapsed Multiple Myeloma Patients

Douglas W Sborov, MD MS, Flavia Pichiorri, PhD MSC, Gerard J Nuovo, MD, Don M Benson, MD PhD, Yvonne A. Efebera, MD MPH, Ashley E Rosko, MD, Craig C Hofmeister, MD MPH
Journal: Blood
Blood (2015) 126 (23): 1835.
https://doi.org/10.1182/blood.V126.23.1835.1835
Published: 2015
Journal Articles

The Majority of Myeloma Patients Are Hypogonadal but This Is Not Associated with High Risk Cytogenetics

Beau Snoad, Samantha Hudzik, Douglas W Sborov, MD MS, Nita Williams, Desiree Jones, Craig C Hofmeister, MD MPH
Journal: Blood
Blood (2015) 126 (23): 5329.
https://doi.org/10.1182/blood.V126.23.5329.5329
Published: 2015
Journal Articles

2-Hour Cryotherapy Effectively Reduces Severe Mucositis Associated with High-Dose Melphalan Followed By Stem Cell Rescue: Results from a Randomized Trial

Douglas W. Sborov, MD, Misty Lamprecht, CNS, Don Benson, MD PhD, Karen Tackett, RN, Yvonne A Efebera, MD, Rosko E Ashley, MD, Steven M. Devine, MD, Ming Poi, PharmD, PhD, Mitch A. Phelps, PhD, Craig C Hofmeister, MD MPH
Journal: Blood
Blood (2014) 124 (21): 3960.
https://doi.org/10.1182/blood.V124.21.3960.3960
Published: 2014
Journal Articles

Development of a Predictive Pharmacokinetic and Pharmacodynamic Model to Personalize Melphalan Dosing in Autologous Transplant for Patients with Multiple Myeloma

Yu Kyoung Cho, MS, Junan Li, PhD, Douglas W. Sborov, MD, Jiang Wang, PhD, Yue Gao, PhD, Misty Lamprecht, CNS, Ming Poi, PharmD, PhD, Mitch A. Phelps, PhD, Craig C Hofmeister, MD MPH
Journal: Blood
Blood (2014) 124 (21): 1086.
https://doi.org/10.1182/blood.V124.21.1086.1086
Published: 2014
Journal Articles

HDAC Inhibitor AR-42 Decreases CD44 Expression and Sensitizes Myeloma Cells to Lenalidomide

Hector Cordero-Nieves, BS, Douglas W. Sborov, MD, Alessandro Canella, MS, Zhongfa Liu, Jessica Consiglio, MS, Wenjun Ni, Emily Smith, Lara Rizzotto, PhD, Yvonne A Efebera, MD, Don M. Benson, MD PhD, Luciano Cascione, Mo Xiaokui, MS, John C. Byrd, MD, Michael R. Grever, MD, Craig C Hofmeister, MD MPH, Flavia Pichiorri, PhD
Journal: Blood
Blood (2014) 124 (21): 3377.
https://doi.org/10.1182/blood.V124.21.3377.3377
Published: 2014
Journal Articles

A Phase 1 Trial Of Reolysin Alone In Patients With Refractory Or Relapsed Multiple Myeloma

Douglas W. Sborov, MD, Gerard Nuovo, PhD, Andrew Stiff, BS, Thomas Mace, PhD, Gregory Lesinski, PhD, MPH, Don M. Benson, Jr., MD, PhD, Yvonne A Efebera, MD, Ashley E. Rosko, MD, Flavia Pichiorri, PhD, Craig C Hofmeister, MD
Journal: Blood
Blood (2013) 122 (21): 3208.
https://doi.org/10.1182/blood.V122.21.3208.3208
Published: 2013
Journal Articles

Understanding The Differential Response Of Multiple Myeloma To Reovirus Treatment

Andrew Stiff, BS, Joseph Badway, B.S., Gerard Nuovo, PhD, Douglas W. Sborov, MD, Emily M Smith, BS, Tiffany Talabere, Craig C Hofmeister, MD, Flavia Pichiorri, PhD
Journal: Blood
Blood (2013) 122 (21): 3232.
https://doi.org/10.1182/blood.V122.21.3232.3232
Published: 2013